Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP418411.RA_Ym460AvdMSClK0TQz3BW1QOxgpP4Rlc-mkKIvj7VXY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP418411.RA_Ym460AvdMSClK0TQz3BW1QOxgpP4Rlc-mkKIvj7VXY130_assertion type Assertion NP418411.RA_Ym460AvdMSClK0TQz3BW1QOxgpP4Rlc-mkKIvj7VXY130_head.
- NP418411.RA_Ym460AvdMSClK0TQz3BW1QOxgpP4Rlc-mkKIvj7VXY130_assertion description "[TERC is a likely target of the 3q26 amplification, and, therefore, may be a useful biomarker for diagnosis and an attractive, novel target for molecular therapy of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418411.RA_Ym460AvdMSClK0TQz3BW1QOxgpP4Rlc-mkKIvj7VXY130_provenance.
- NP418411.RA_Ym460AvdMSClK0TQz3BW1QOxgpP4Rlc-mkKIvj7VXY130_assertion evidence source_evidence_literature NP418411.RA_Ym460AvdMSClK0TQz3BW1QOxgpP4Rlc-mkKIvj7VXY130_provenance.
- NP418411.RA_Ym460AvdMSClK0TQz3BW1QOxgpP4Rlc-mkKIvj7VXY130_assertion SIO_000772 14581340 NP418411.RA_Ym460AvdMSClK0TQz3BW1QOxgpP4Rlc-mkKIvj7VXY130_provenance.
- NP418411.RA_Ym460AvdMSClK0TQz3BW1QOxgpP4Rlc-mkKIvj7VXY130_assertion wasDerivedFrom befree-2016 NP418411.RA_Ym460AvdMSClK0TQz3BW1QOxgpP4Rlc-mkKIvj7VXY130_provenance.
- NP418411.RA_Ym460AvdMSClK0TQz3BW1QOxgpP4Rlc-mkKIvj7VXY130_assertion wasGeneratedBy ECO_0000203 NP418411.RA_Ym460AvdMSClK0TQz3BW1QOxgpP4Rlc-mkKIvj7VXY130_provenance.